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Zinc is an essential trace metal for bacteria of the intestinal flora. Approximately 20%
of dietary zinc – intake is used by intestinal bacteria. The microbiome has recently
been described as an important factor for healthy brain function via so-called gut-
brain interactions. Similarly, zinc deficiency has been associated with neurological
problems such as depression, mental lethargy and cognitive impairments in humans
and animal models. However, the underlying pathomechanisms are currently not well
understood and a link between zinc deficiency and altered microbiota composition
has not been studied. Especially during pregnancy, women may be prone to low zinc
status. Thus, here, we investigate whether zinc deficiency alters gut-brain interaction in
pregnant mice by triggering changes in the microbiome. To that end, pregnant mice
were fed different diets being zinc-adequate, deficient in zinc, or adequate in zinc
but high in zinc uptake antagonists for 8 weeks. Our results show that acute zinc-
deficient pregnant mice and pregnant mice on a diet high in zinc uptake antagonists
have an altered composition of gastro-intestinal (GI) microbiota. These changes were
accompanied by alterations in markers for GI permeability. Within the brain, we found
signs of neuroinflammation. Interestingly, microbiota composition, gut pathology, and
inflammatory cytokine levels were partially rescued upon supplementation of mice with
zinc amino-acid conjugates (ZnAA). We conclude that zinc deficiency may contribute
to abnormal gut-brain signaling by altering gut physiology, microbiota composition and
triggering an increase of inflammatory markers.
Keywords: Zn, microbiota, gastrointestinal, gut-brain, postpartum depression, mood disorder, immune disease,
trace metal
INTRODUCTION
Zinc is one of the most prevalent trace metal ions in the body and plays a major
role in the functions of the brain, immune system and endocrine system (Sauer et al.,
2016). In humans, acute zinc deficiency is associated with the occurrence of skin
lesions, anorexia, diarrhea, growth retardation, depressed wound healing, altered immune
function, sensory impairments, and behavioral changes such as lethargy and depression
(Aggett and Harries, 1979; Chasapis et al., 2012). Especially the ability to precipitate
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depression hints toward an interesting gut-brain interaction,
given that zinc required for cognitive processes is ultimately
taken up via the gastrointestinal (GI) system (Vela et al., 2015;
Rafalo et al., 2016).
Low zinc status has been associated with several mood
disorders including major depressive disorders and bipolar
depression (Cope and Levenson, 2010). Depression is a mental
disorder caused by changes in brain chemistry affecting thought
processes, emotions, behaviors and overall physical health
(Bondy, 2002). Interestingly, zinc status may be a biomarker
of mood disorder (Styczeń et al., 2017). Several studies show
that zinc deficiency induces depression while supplementing zinc
improves mood as well as cognitive function in humans with
depression and animal models (Piao et al., 2017).
Clinical studies have reported a reduction of blood zinc
concentration in depressed patients (McLoughlin and Hodge,
1990; Maes et al., 1997; Siwek et al., 2013; Swardfager et al., 2013;
Pfaender and Grabrucker, 2014) A recent meta-analysis found
that depression in subjects was associated with significantly lower
peripheral blood zinc concentration (Swardfager et al., 2013).
Interestingly, lower zinc blood concentrations were also reported
in women with postpartum depression (Etebary et al., 2010).
In animal models, acute zinc deficiency often was reported
to result in depression-like behavior (Hagmeyer et al., 2014).
The administration of low zinc diets leads to the development
of depressive-like behavior in mice and rats (Tassabehji et al.,
2008; Watanabe et al., 2010; Młyniec and Nowak, 2012;
Młyniec et al., 2012, 2013a,b), assessed through measuring
immobility time in the forced swim test (Corniola et al.,
2008; Tassabehji et al., 2008; Whittle et al., 2009; Watanabe
et al., 2010; Młyniec et al., 2012, 2013b) or tail suspension
test (Młyniec and Nowak, 2012), indicating that zinc deficiency
contributes to the development of this behavior. However,
the underlying molecular pathomechanisms are still not well
known. On a molecular level, zinc has been associated with the
GPR39 receptor modulating monoaminergic and glutamatergic
neurotransmission, NMDA receptor signaling (Paoletti et al.,
2009), glucocorticoids (Nowak, 2001), and BDNF levels, which
are all affected in depression (Młyniec et al., 2015). Further,
zinc deficiency can disrupt energy metabolism and contributes to
chronic inflammation (Bao et al., 2010). There is a tight interplay
between zinc levels and inflammation (Prakash et al., 2015),
with decreased zinc associated with a pro-inflammatory state.
In particular, increased levels of circulating pro-inflammatory
cytokines, which may lead to the activation of brain-resident
microglia may contribute to neurobiological changes seen in
depression (Wohleb et al., 2016) such as dysfunction of the
monoamine system, impaired neurogenesis, and alterations in
synaptic function (Horowitz and Zunszain, 2015) that result in
abnormalities in regional brain activity.
While zinc deficiency negatively affects mood possibly
triggering the development of depressive-like symptoms,
evidence is mounting that zinc supplementation can be used to
improve depressive symptoms in humans and animal models
(Nowak et al., 2003; Siwek et al., 2010; Petrilli et al., 2017).
Zinc supplementation exhibits antidepressant-like effects
in both preclinical and clinical studies (Nowak et al., 2003;
Siwek et al., 2009). In addition, the results of several randomized
controlled trials show effectiveness of zinc as adjunctive therapy
in depressed individuals (Nowak et al., 2003; Siwek et al., 2009;
Sawada and Yokoi, 2010; Lai et al., 2012; Ranjbar et al., 2014;
Solati et al., 2015). Similarly, the treatment of animal models
for depression with zinc showed antidepressant effects, and zinc
supplementation enhanced the effectiveness of antidepressants
(Rafalo et al., 2016).
Zinc is also an essential trace metal for bacteria of the
intestinal flora. A comparison between germ-free rats and rats
with pathogen-free intestinal flora revealed that approx. 20% of
the dietary intake of zinc was used by intestinal bacteria (Smith
et al., 1972). Intriguingly, changes in gut microbiota have been
implicated in a variety of conditions including depression (Dinan
and Cryan, 2017). In a recent study, depression was reported
associated with decreased gut microbiota richness and diversity
(Kelly et al., 2016). A feedback loop between depressive states
and dysregulation of the microbiome was suggested. An open
question is, whether zinc deficiency alone may correspondingly
alter the gut microbiome as demonstrated in mice in which
chronic depression- and anxiety-like behaviors were induced by
olfactory bulbectomy (Park et al., 2013).
In mice, the offspring of mice with zinc deficiency during
pregnancy show autism-like behavior (Grabrucker et al., 2014,
2016). Intriguingly, in humans, maternal postpartum depression
is associated with the presence of autistic traits in the offspring at
18 months of age (Salvanos et al., 2010). Pregnant women are at
increased risk of developing zinc deficiency as the required daily
intake almost doubles in this period (Grabrucker, 2016). Further,
supplementation of folic acid, high levels of calcium and iron, as
well as a diet high in phytates may lower the bioavailability of zinc
(Sauer et al., 2017) during pregnancy.
Thus, here, we investigated whether dietary-induced acute
zinc deficiency during pregnancy can elicit alterations in the gut
microbiota composition in pregnant mice, which may translate
into increased inflammatory signaling and ultimately induce
changes in brain function in mice. We included a diet adequate
in zinc but enriched in zinc uptake inhibitors (folic acid, phytic
acid, high Ca/Fe) for comparison with a diet deficient in zinc
in our study. We further investigated whether rescuing zinc
levels using zinc amino-acid conjugates (ZnAA) ameliorates
the observed alterations and thus may be a potential future
prevention strategy. ZnAAs have advantages in overcoming
especially low bioavailability of zinc (Sauer et al., 2017) and are
currently available on the market as a mineral supplement for
animals, where they are safe and effective and may be used in
human studies in future.
MATERIALS AND METHODS
Materials
PBS with Ca2+/Mg2+ was purchased from PAA.
Paraformaldehyde was purchased from Merck, and D-Saccharose
from Carl Roth. Unless otherwise indicated, all other chemicals
were obtained from Sigma-Aldrich. Primary antibodies were
purchased from the following companies: Thermo Fisher
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Scientific (ZO-1 polyclonal antibody, 61-7300, mouse specific;
FABP2 polyclonal antibody, PA5-18700, mouse specific), Abcam
(Anti-Claudin 3 polyclonal antibody, ab15102, mouse specific;
Anti-GFAP monoclonal antibody [GF5], ab10062, mouse
specific), Origene (monoclonal antibody to Escherichia coli LPS
(J5 LPS)[Clone ID: 2D7/1], BM1091, besides E. coli J5 LPS,
the antibody has also been found to react with K. pneumoniae,
S. sonnei, and S. typhimurium LPS, the antibody detects LPS
and LPS with modifications), Cell signaling Technologies (IL-6
(D5W4V) XP monoclonal antibody, #12912, mouse specific),
Sigma Aldrich (Anti-Iba1/AIF1 monoclonal antibody, MABN92,
mouse specific) and Merck Millipore (Anti-NR2B polyclonal
antibody, 06-600, mouse specific). Alexa Fluor conjugated
secondary antibodies were obtained from Invitrogen/Life
Technologies Europe. Secondary HRP conjugated antibodies
were purchased from Dako. Zinc amino acid complexes (ZnAAs)
were obtained from Zinpro Corporation (Eden Prairie, MN,
United States). Special diets for mice were purchased from
Ssniff diets, Germany.
Animals
8-week old C57BL/6JRj mice were purchased from Janvier Labs
and housed upon arrival in the animal facility in plastic cages
under standard laboratory conditions and provided with food
and water available ad libitum. The housing room was maintained
at 22◦C, with lights automatically turned on/off in a 12 h rhythm
(lights on at 7 am). After 2 weeks of acclimation, mice were
divided into 4 groups: the control group (3 females) was fed with
standard laboratory food (41 mg/kg zinc) (diet 1), the second
group (3 females) was fed a zinc-deficient diet (19 mg/kg zinc)
(diet 2). The third group received the standard laboratory food
(41 mg/kg zinc), with increased levels of phytates (9.5 mg/kg),
folic acid (1.9 mg/kg), Ca (1.13 mg/kg) and Fe (503 mg/kg)
(diet 3). The fourth group was given diet 3 with 41 mg/kg
ZnAA supplement (Sauer et al., 2017). Mice were given access to
distilled, demineralized drinking water ad libitum. After 5 weeks,
animals became pregnant and were maintained for 3 weeks of
pregnancy on the respective diet. All animal experiments were
performed in accordance with the guidelines and regulations
for the welfare of experimental animals issued by the Federal
Government of Germany and by the local ethics committee
(Ulm University). The protocol used was approved by the
Regierungspräsidium Tübingen, state of Baden-Württemberg,
and the Ethics Committee of Ulm University (ID Number: 1257).
Measurement of Trace Metal
Concentrations
The Zn-concentration of solutions was measured by flame atomic
absorption spectrometry (AAS) at the Department of Clinical
Chemistry (ZE klinische Chemie) of the University Hospital Ulm
using a PinAAcle 900T from Perkin Elmer.
Immunohistochemistry
Frozen brain sections were cut at 14 µm thickness with
a cryostat (Leica CM3050 S) and stored at −80◦C until
further use. Prior to fluorescent staining, sections were thawed
for 20 min in a hydrated staining chamber, fixed in 4%
paraformaldehyde (PFA)/4% sucrose/PBS for 20 min and washed
three times in PBS for 5 min each. Then, sections were
treated with 1x PBS with 0.2% Triton X-100 for 20 min
at RT and 1 × PBS with 0.05% Triton X-100 for 10 min
at RT. To prevent unspecific antibody binding, blocking was
performed with blocking solution (BS) (10% FBS in 1x PBS)
for 1 h at RT. Primary antibodies were diluted in BS and
incubated overnight at 4◦C in a humid chamber. Subsequently,
sections were washed 1 × PBS with 0.05% Triton X-100
for 10 min and then incubated in a humidity chamber with
secondary antibody (alexa488 or alexa568) in BS for 2 h at
37◦C in darkness. After washing of tissue with 1 × PBS
plus 0.05% Triton X-100 for 5 min each for three times,
and additionally 5 min in 1× PBS, brain sections were
counterstained with DAPI (4′,6-Diamidin-2-phenylindol) for
5 min at RT. After washing with aqua bidest, sections were
mounted with Vecta Mount. Fluorescence images were obtained
using an inverted confocal microscope (Zeiss LSM710) and
an ImageXpress Micro Spinning Disc Confocal High-Content
Imaging System (Molecular Devices), and analyses of signal
intensities were performed with ImageJ 1.48r. For quantitative
analysis, signals were thresholded and signal intensities of
GFAP/IL-6 immunoreactivity in the vicinity of DAPI labeled
cell nuclei measured using the selection tool to determine
cytoplasmic protein levels. Exposure times and threshold values
were equal for all groups. Brain sections from three animals
per group were used and signal intensities from 10 cells
from three sections per animal measured in the hippocampal
CA1+ CA2 area.
Protein Biochemistry
Liver tissue was immersed in Hepes Sucrose buffer (10 mM
Hepes, 0.32 M Sucrose) and disrupted using a sonicator
(Fisherbrand sonic dismembranator 120). To obtain homogenate
from GI tissue, gut mucus was removed by gently squeezing
it out of the intestine with the blunt point of tweezers, and
tissue was submerged in PBS. Afterward the cleaned tissue
was lysed in modified RIPA buffer (150 mM sodium chloride,
50 mM Tris–HCl, pH 7.4, 1 mM ethylenediaminetetraacetic
acid, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1%
sodium dodecylsulfate) plus added protease inhibitor cocktail
(complete EDTA-free Protease Inhibitor Cocktail tablets,
Roche). Tissue samples in lysis buffer were disrupted with a
sonicator (Fisherbrand sonic dismembrator 120). Afterward
the obtained homogenate was incubated for 2 h at 4◦C on
a rotator. Besides semi-quantitative measurement of protein
levels, the resulting lysate allows for the analysis of LPS in
tissue. All materials used for lysate preparation were sterile
and endotoxin-free.
LPS analysis was performed according to Sturm et al. (1984).
The optional step of “baking” the nitrocellulose membrane
after transfer was not performed due to simultaneous detection
of ACTIN. Therefore, more diffuse LPS banding patterns are
observed representing higher molecular weight LPS molecules.
Using this protocol, the detection of LPS is limited to molecules
having side chain lengths of approx. 30 repeat units and greater.
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Western Blotting
Protein concentrations were determine by Bradford protein assay
and Pierce BCA Protein assay, and equal concentrations loaded
per lane. Proteins were separated by SDS-PAGE and blotted onto
nitrocellulose membranes (GE Healthcare). Immunoreactivity
was visualized using horseradish peroxidase (HRP)-conjugated
secondary antibodies and Pierce SuperSignal ECL substrate
(Thermo Fisher Scientific).
Western Blot Quantification
Evaluation of bands from Western blots (WBs) was performed
using ImageJ. Three independent experiments were performed
and blots imaged using a UVITEC Alliance Q9 Advanced system.
The individual bands were selected and the integrated density
was measured. All WB bands were normalized to β-Actin and
the ratios averaged and tested for significance. Mean β-Actin
signals were measured and compared between groups to exclude
effects of the treatments on the proteins used for normalization.




DNA extraction of murine fecal samples was performed using
the Mo Bio PowerFecal DNA Isolation Kit according to the
manufacturer′s protocol. The resulting DNA concentration
was measured on a Nanodrop 2000. Purity was assessed by
calculating the measured A260/A280 ratio. DNA samples with
an A260/A280 ratio between 1.7 to 2.0 were considered pure and
subsequently used for microbiome profiling.
Pyrosequencing of 16S rDNA Region V3–V5
Primers were designed to target conserved sequences around
the variable region 3–5 (V3–V5) of bacterial 16S rDNA. All
bacterial taxonomic profiling via Illumina MiSeq was performed
by Eurofins Genomics (Ebersberg, Germany).
Pyrosequencing Data Processing and Taxonomic
Classification
All reads with errors were removed from the data set. Processing
of remaining reads was performed using minimum entropy
decomposition (MED), while splitting up the marker gene
dataset into Operational Taxonomic Units (OTUs). Assignment
of taxonomic information to each OTU was performed by BLAST
aligning of cluster representative sequences to the NCBI sequence
database. As a minimal requirement for reference sequences,
only sequences with a sequence identity of 80% across at least
80% of a representative sequence were chosen. For each OTU
a specific taxonomic assignment was transferred, selected from
a set of best matching reference sequences. Using the QIIME
software (version 1.8.0), taxonomic assignments and OTUs were
processed further.
Gene Expression Analysis (qRT-PCR)
Total RNA from murine brain tissue was isolated with the RNeasy
Lipid Tissue Kit (Qiagen) according to the manufacturer’s
protocol. Elution of total RNA was performed with sterile RNAse-
free water. RNA concentration was measured with the Take3 plate
on the Synergy H1 plate reader (Biotek). RNA purity was assessed
by A260/A280 absorbance ratio. For each biological replicate the
same amount of RNA was used per run. Quantitative RT-PCR
was performed using the QuantiFast SYBR Green RT-PCR kit
(Qiagen) and QuantiTect Primers (Qiagen) in a total volume of
10 µl. Thermal cycling and fluorescent detection were performed
using the QuantStudioTM 7 Flex Real-Time PCR System (Applied
Biosystems), measuring the SYBR Green I reporter dye signal.
Transcript levels were normalized to the housekeeping gene
Hmbs. All cycle threshold values (ct) were calculated by the
QuantiStudio Real-Time PCR software. All PCR reactions were
run in triplicates.
qRT PCR Quantification
Relative quantification is based on internal reference genes to
determine virtual mRNA levels of target genes. Ct values were
transformed into virtual mRNA levels according to the formula:




Bacterial endotoxins in murine liver tissue samples were
measured with the Pierce LAL (Limulus Amebocyte Lysate)
Chromogenic Endotoxin Quantitation Kit (Thermo Fisher)
according to the manufacturer′s protocol. All materials used for
endotoxin measurement in samples were sterile and endotoxin-
free (e.g., Fisherbrand DNase/RNase and pyrogen free 1.5 ml
tubes, Eppendorf ep Dualfilter T.I.P.S R© SealMax). Liver samples
were homogenized in Hepes Sucrose buffer using a sonic
dismembrator (Fisherbrand) and diluted in endotoxin-free water
for the assay. Absorbance levels of standards and samples were
measured at 405 nm with the Synergy H1 plate reader (Biotek).
With the help of a standard curve, endotoxin levels [endotoxin
units/ml (EU/ml)] in liver samples were calculated.
Statistics
Statistical analysis was performed with Sigmaplot 11.0 and
GraphPad Prism 5. Data are shown as mean ± SEM. For
multiple-group comparisons, analysis of variance (ANOVA) was
performed. If groups showed significant differences post hoc
tests for within-group comparisons were performed (Tukey test).
For comparisons of two independent groups, student’s t-tests
were used. Statistically significant differences are indicated in the
figures by ∗p ≤ 0.05, ∗∗p ≤ 0.01, and ∗∗∗p ≤ 0.001.
RESULTS
Low Levels of Zinc and Low Zinc
Bioavailability Both Lead to Acute Zinc
Deficiency in Mice
To understand the relationship of zinc deficiency, microbiome,
and brain physiology, female wild type C57BL/6 mice (10 weeks
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FIGURE 1 | Whole-blood Zn levels of mice measured by AAS in three animals
per group. Animals on a control diet (35 ppm) show average zinc levels of
66.7 µmol/l. After 8 weeks on a zinc-deficient diet (<5 ppm), significantly
lower zinc levels are measured. Mice on a diet with control zinc levels
(35 ppm) but the bioavailability of zinc lowered due to the presence of
antagonists of absorption (Zn inhibitor) similarly to mice on a zinc-deficient diet
show a significant reduction in whole-blood zinc levels.
of age) were fed 3 different diets for 8 weeks. Mice received either
a control diet with adequate supply of all necessary nutrients
including zinc (Control diet), a diet low in zinc (Zn deficient
diet) that was shown to produce mild zinc deficiency before
(Grabrucker et al., 2016), or the control diet with increased levels
of Zn uptake inhibitors (phytates, Ca and Fe, and folic acid) (Zn
inhibitor diet). Average whole-blood zinc levels were investigated
in three animals per group (Figure 1). A reduction of zinc in
whole-blood does not only reflect decreased zinc levels of a fast
exchanging pool of plasma zinc but indicates a zinc deficiency
affecting also intracellular zinc levels of blood cells and most likely
several other tissues.
The results show that animals on a standard control diet
had average whole-blood zinc levels around 67 µmol/l. As
expected from previous studies (Grabrucker et al., 2014, 2016),
a zinc-deficient diet significantly reduced zinc levels compared
to mice on the control diet (one way ANOVA, F(2,6) = 8.739,
p = 0.017, Post hoc analysis: Control vs. Zinc deficient, p = 0.0461).
Interestingly, the presence of additional phytates, folic acid, and
Ca and Fe ions (zinc uptake antagonists) also led to a significant
reduction in zinc levels (Figure 1) (Control vs. Zinc inhibitor,
p = 0.0307). Thus, the presence of high phytate levels such as
found in a plant-rich diet and folic acid and mineral (Ca, Fe)
supplements significantly lowers zinc bioavailability in the diet
to a level comparable to a zinc depleted diet in these experiments.
Low Dietary Levels or Bioavailability of
Zinc Result in Altered Microbiota
Composition in Pregnant Mice
Next, to investigate whether low dietary zinc availability over a
period of 8 weeks is sufficient to induce alterations in the gut
microbiota composition of mice, we performed pyrosequencing
of 16S rDNA of fecal samples. A microbiome profile of mice
from all different groups was established (Figure 2). The results
show that both Zn deficient diet and the Zn inhibitor diet lead
to significantly different microbiota composition in pregnant
mice (Figure 2A). However, the microbiota composition was also
different between Zn deficient diet and the Zn inhibitor diet.
Thus, in the presence of zinc uptake antagonists, some microbiota
are still successfully able to compete for zinc. In general, on
phylum level, Verrucomicrobia were the most prevalent in
control mice. In mice on a zinc-deficient diet, Verrucomicrobia
levels are dramatically reduced and Firmicutes become by far
the most prevalent microbiota phylum. In mice on a diet with
adequate zinc levels but the presence of zinc uptake antagonists,
Verrucomicrobia levels are similar to control mice but Firmicutes
increase as well. A significantly higher number of different species
was detected in the microbiome of animals on a zinc-deficient
diet compared to animals on control diet (one way ANOVA,
p = 0.002, Post hoc analysis: Control vs. Zinc deficient, p = 0.0167)
(data not shown).
In detail (Figure 2B), a significant difference was found in
the phylum Actinobacteria (one way ANOVA, p = 0.00003).
While no difference was found between control and Zn inhibitor
diet, mice on Zn deficient diet had significantly higher levels of
Actinobacteria compared to controls and mice on Zn inhibitor
diet (Tukey post hoc analysis: Control vs. Zinc deficient, p < 0.01;
Control vs. Zinc inhibitor, p < 0.01). In addition, levels of
Bacterioidetes were significantly different (one way ANOVA,
p = 0.00004). Mice on Zn deficient diet showed significantly
increased levels compared to control and Zn inhibitor diet
(Tukey post hoc analysis: Control vs. Zinc deficient, p < 0.01;
Zinc deficient vs. Zinc inhibitor, p < 0.01). Further, both Zinc
deficient and Zinc inhibitor diets significantly increase the level
of Firmicutes compared to the control diet (one way ANOVA,
p = 0.00003; Tukey post hoc analysis: Control vs. Zinc deficient,
p < 0.01; Control vs. Zinc inhibitor, p < 0.01). The increase was
significantly higher in mice on a zinc-deficient diet (Zinc deficient
vs. Zinc inhibitor, p < 0.01).
In contrast, both Zinc deficient and Zinc inhibitor diets
significantly decrease the level of Proteobacteria compared to
the control diet (one way ANOVA, p = 0.0003; Tukey post hoc
analysis: Control vs. Zinc deficient, p < 0.01; Control vs. Zinc
inhibitor, p < 0.01). The decrease was significantly higher in
mice on a zinc inhibitor diet (Zinc deficient vs. Zinc inhibitor,
p < 0.01). Zinc depleted diet, but not the diet with adequate
zinc levels and presence of zinc uptake inhibitors dramatically
reduced the amount of Verrucomicrobia (one way ANOVA,
p = 0.0006; Tukey post hoc analysis: Control vs. Zinc deficient,
p < 0.01; Zinc deficient vs. Zinc inhibitor, p < 0.01). The number
of unclassified reads was significantly higher in mice on a zinc-
deficient diet (Figure 2C).
Based on the alterations observed on the phylum level, we
conclude that the phylum Proteobacteria is very sensitive to
zinc depletion as already lower bioavailability of zinc leads
to a significant decrease of this phylum. However, within
the phylum, not all classes respond similarly. For example,
while Epsilonproteobacteria and Betaproteobacteria are highly
reduced by zinc restriction, Deltaproteobacteria slightly increase
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FIGURE 2 | Continued
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FIGURE 2 | DNA was extracted from feces from three animals per group and microbiota composition analyzed using 16s microbiome profiling. (A,B) On phylum
level, significant differences were detected. (A) Using the obtained sequence information, single species and their relative amounts were identified. Each phylum was
assigned a color. Both, relative abundance and the composition of species are different between the three groups. Verrucomicrobia is the most prevalent phylum in
control mice. On a zinc-deficient diet, Verrucomicrobia levels are reduced and Firmicutes are the most prevalent phylum. Mice on the Zn inhibitor diet show an
intermediate microbiome with Verrucomicrobia levels similar to controls but also an increase in Firmicutes. (B) While no difference was found between the control
and Zn inhibitor diet, mice on Zn deficient diet had significantly higher levels of Actinobacteria compared to controls and mice on the Zn inhibitor diet. Levels of
Bacterioidetes were significantly increased in mice on Zn deficient diet compared to the control and Zn inhibitor diet. Zn deficient and Zn inhibitor diets significantly
increase the level of Firmicutes. The increase was significantly higher in mice on a Zn deficient diet. The level of Proteobacteria significantly decreases in mice on Zn
deficient and Zn inhibitor diet. The decrease was significantly higher in mice on a Zn inhibitor diet. Zn deficient but not Zn inhibitor diet significantly reduces the
amount of Verrucomicrobia. (C) The number of unclassified reads was significantly higher in mice on a zinc-deficient diet. (D) Left panel: Proteobacteria are highly
sensitive to zinc depletion with a significant decrease occurring both on Zn deficient and Zn inhibitor diet. Although Epsilonproteobacteria and Betaproteobacteria are
significantly reduced by zinc restriction, Deltaproteobacteria increase. Middle panel: Verrucomicrobia are not altered under the Zn inhibitor diet, but significantly
reduced in mice on a Zn deficient diet. Bacterioidetes, especially Bacteriodia, significantly increase on a Zn deficient diet. Right panel: Firmicutes significantly
increase under Zn deficient and Zn uptake inhibition. (E) Lachnospiraceae are significantly increased on a Zn deficient diet. Ruminococcaceae are more
characteristic of a Zn inhibitor diet. (F) A more than fivefold increase in mice on Zn deficient or Zn inhibitor is found in the genus Bifidobacterium (Bifidobacterium
pseudolongum), Olsenella, Asaccharobacter (Asaccharobacter WCA-131-CoC-2), Eggerthella (Eggerthella YY7918), Enterorhabdus (Enterorhabdus mucosicola),
Odoribacter (Odoribacter laneus), Eubacterium (Eubacterium plexicaudatum), Anaerostipes (Anaerostipes butyraticus), and Lachnoclostridium (Lachnoclostridium
scindens). The most significant and largest increase was seen in the genus Murimonas (Murimonas intestine) under Zn deficient conditions. Ruminococcus
(Ruminiclostridium cellobioparum) display the largest increase under Zn uptake inhibition. Bacteria of the genus Acetatifactor, Desulfonispora, Ercella, Sporobacter,
Holdenmanella, Kiloniella, Rhodospirillum, Caldimones, and Xenophilus were highly reduced or absent in mice on Zn deficient and Zn inhibitor diet.
(Figure 2D). In contrast, the phylum Firmicutes thrives under
low zinc conditions (Figure 2D). Verrucomicrobia can cope
with low bioavailability of zinc and seem to have mechanisms
of zinc intake that successfully compete with the presence of
uptake inhibitors. However, under zinc-depleted conditions, the
presence of the phylum in the gut microbiome is drastically
reduced. Bacterioidetes, especially the class Bacteriodia, are
more successful in populating the gut microbiome under zinc
depletion (Figure 2D).
Given that the loss of Proteobacteria and an increase in
Firmicutes occurs in both zinc restricted diets, we closer analyzed
the composition of Firmicutes to investigate, which bacteria
increase in numbers or are newly found in the GI tract of
these mice (Figure 2E). We found that especially the Firmicutes
family Lachnospiraceae benefits from zinc depleted conditions,
while Ruminococcaceae are more characteristic for a diet high
in zinc uptake antagonists. Changes in the occurrence of
members of the Lachnospiraceae have been associated with
chronic inflammation of the gut (Manichanh et al., 2006;
Berry et al., 2012).
Finally, we analyzed the different microbiomes on
genus level (Figure 2F). Among 223 different genera, we
highlight those that show a more than 5-fold increase in
mice on zinc-deficient or zinc inhibitor diet and those
being lost from the microbiome in both zinc deficient or
zinc inhibitor diets. We found an increase in the genus
Bifidobacterium mostly due to an increase in Bifidobacterium
pseudolongum, Olsenella, Asaccharobacter due to an increase
in Asaccharobacter WCA-131-CoC-2, Eggerthella due to an
increase in Eggerthella YY7918, Enterorhabdus due to an
increase in Enterorhabdus mucosicola, Odoribacter due to an
increase Odoribacter laneus, Eubacterium due to an increase in
Eubacterium plexicaudatum, Anaerostipes due to an increase
Anaerostipes butyraticus, and Lachnoclostridium due to an
increase Lachnoclostridium scindens. A very large increase
was found in the genus Murimonas, especially Murimonas
intestine under zinc-deficient conditions, which may be a
potent biomarker for zinc deficiency (Figure 2F). The genus
Ruminococcus, especially Ruminiclostridium cellobioparum
shows a specific increase in mice on the zinc inhibitor
diet (Figure 2F).
The genus Turicibacter, Allobaculum, Marvinbryantia, and
Butyrivibrio only appeared in the microbiome of mice on zinc-
deficient or zinc inhibitor diets (not shown).
Low Dietary Levels or Bioavailability of
Zinc Result in Altered Gut Physiology
Enterorhabdus mucosicola was originally isolated from inflamed
ileal samples of TNFdeltaARE mice (Clavel et al., 2009). In addition,
both E. plexicaudatum and E. mucosicola are associated with
inflamed gut mucosa and intestinal epithelial barrier dysfunction.
Further, Egerthella YY7918 is closely related to the type strain
Eggerthella lenta VPI0255. Eggerthella lenta has been to be part of
the normal human intestinal microbiome and has been associated
with infections of the gastrointestinal tract (Gardiner et al., 2015).
Therefore, next, we evaluated markers of intestinal physiology
and “leakiness”.
We selected three markers, FABP2 (Intestinal fatty acid-
binding protein 2), CLAUDIN3, and ZONULIN1 (HP1)
(Figures 3A–C). FABP2 is a cytosolic protein found in small
intestine epithelial cells where it participates in the uptake,
intracellular metabolism, and transport of long-chain fatty acids.
CLAUDIN3 is a cell adhesion protein found at tight junctions
between gut epithelial cells. ZONULIN1 is a physiological
modulator of intercellular tight junctions and alterations in the
ZONULIN regulated pathways have been associated with both
intestinal and extra-intestinal autoimmune and inflammatory
disorders (Fasano, 2011). ZONULIN1 and FABP2 have been
proposed as markers of gut dysbiosis and gut permeability
integrity (Stevens et al., 2018), with a decrease in FABP2 and
an increase in ZONULIN1 linked to increased gut permeability
(Fasano, 2012).
While we found no significant differences in the lysate
from the entire small intestine for FABP2 (Figure 3A), mice
on a zinc-deficient diet had significantly reduced levels of
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FIGURE 3 | (A–C) Gastro-intestinal epithelium was isolated from three mice per group and protein lysates analyzed using Western blotting. (A) No significant
differences in FABP2 were detected. (B) Mice on a Zn deficient diet had significantly reduced levels of CLAUDIN3. (C) ZONULIN1 was significantly increased in mice
on Zn inhibitor diet. (D) Liver tissue was isolated from three mice per group and protein lysates analyzed for the levels of E. coli lipopolysaccharide (LPS) using
Western blotting. A significant increase in liver LPS is visible in mice on a Zn deficient and Zn inhibitor diet. (E) LPS levels were measured by LAL assay from three
mice per group in triplicates. The results show significantly increased LPS levels in liver lysate from mice on Zn deficient and Zn inhibitor diet compared to controls.
CLAUDIN3 (Figure 3B) (one way ANOVA, p = 0.0084; Tukey
post hoc analysis: Control vs. Zinc deficient, p = 0.0068),
and mice on Zinc inhibitor diet showed a trend toward
a reduction. ZONULIN1 was significantly increased in mice
on Zinc inhibitor diet (Figure 3C) (one way ANOVA,
p = 0.0046; Tukey post hoc analysis: Control vs. Zinc
inhibitor, p = 0.0082) compared to controls and mice on zinc-
deficient diet (Tukey post hoc analysis: Zinc deficient vs. Zinc
inhibitor, p = 0.0069).
The detoxification of microbial products from gut-derived
microbiota is a function of the liver. Analyzing liver tissue
of mice for the levels of E. coli lipopolysaccharide (LPS),
we found a significant increase in liver LPS in mice on
a zinc-deficient and zinc inhibitor diet (one way ANOVA,
p = 0.0054; Tukey post hoc analysis: Control vs. Zinc
deficient, p < 0.05; Control vs. Zinc inhibitor, p < 0.01)
(Supplementary Figure S1A and Figure 3D). To validate
this data, we additionally measured E. coli LPS (endotoxin)
levels in mouse liver using a Limulus Amebocyte Lysate
(LAL) based assay. The results confirm significantly increased
levels of LPS in liver of mice on a zinc-deficient and
zinc inhibitor diet (one way ANOVA, p = 0.047; post hoc
analysis: Control vs. Zinc deficient, p = 0.041; Control vs.
Zinc inhibitor, p = 0.0143) (Supplementary Figure S1B and
Figure 3E). Thus, altered microbiota composition together
with an increased intestinal permeability may be responsible
for increased translocation of bacterial LPS into the systemic
circulation (Szabo et al., 2010).
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Low Dietary Levels or Bioavailability of
Zinc Result in Increased Inflammation in
Pregnant Mice
Given that an increase of ZONULIN1 and loss of CLAUDIN3
have been associated with increased gut permeability and
inflammation, we next analyzed whether we can detect signs of
(neuro)inflammation in the brain of pregnant mice with low
zinc status. To that end, we analyzed tissue for the expression
levels of GFAP and IL-6. Glial fibrillary acidic protein (GFAP) is
an established marker for the activation of astrocytes following
injury or stress (Zhang et al., 2017). Expression of IL-6 was
reported being induced in both astrocytes and microglia in
response to LPS and increased levels in the brain are related
to inflammatory and pathological situations (Erta et al., 2012).
Our results show a significant increase in GFAP expression
levels in brains of mice subjected to zinc deficiency and lowered
bioavailability in the diet compared to control mice (one way
ANOVA, p = 0.0044; Tukey post hoc analysis: Control vs. Zinc
deficient, p = 0.0447; Control vs. Zinc inhibitor, p = 0.0036)
(Figure 4A). The number of GFAP positive cells was not
significantly altered (Figure 4A, lower panel).
The levels of IL-6 were significantly elevated in brain tissue of
both mice on zinc-deficient diet and mice with sufficient dietary
zinc levels but presence of zinc uptake inhibitors compared
to controls (one way ANOVA, p = 0.028; Tukey post hoc
analysis: Control vs. Zinc deficient, p = 0.04547; Control vs. Zinc
inhibitor, p = 0.038557) (Supplementary Figure S2A). However,
measuring IL-6 levels in brain sections by IHC suffers from
specificity and sensitivity issues. Therefore, to further validate the
data from IHC, we assessed IL-6 expression on the transcription
level. The results show a significantly higher concentration of IL-
6 mRNA in the brain of pregnant mice on a zinc-deficient diet
(t-test, p = 0.0041) compared to controls (Figure 4B). Besides,
we detected the increased expression of further inflammatory
marker genes in pregnant mice on a zinc-deficient diet such
as significantly higher levels of IL-1b (p = 0.0034), S100β
(p = 0.0185), and CCL2 (p = 0.0109, t-tests) (Supplementary
Figure S2B). The increased IL-6 transcription translates into
increased IL-6 on protein level, further quantified by western
blotting (t-test, p = 0.0283) (Figure 4C).
Although more extensive analyses need to be done in the
future, the obtained data hint at a physiologic relevant impact
of dietary zinc restriction during pregnancy on the brain
of pregnant mice.
Supplementation of Maternal Diet With
ZnAAs Prevents Several Alterations
Induced by Low Bioavailability of Zinc
Recently, we have investigated the mechanisms of uptake and
absorption of ZnAAs (Sauer et al., 2017). ZnAAs are zinc
supplements with zinc stably conjugated in an amino acid
backbone. These ZnAAs were taken up by cells, not through
classical zinc transporter proteins but amino acid transporters.
Therefore, ZnAAs showed a significant advantage compared to
inorganic zinc salts such as ZnCl2 as a supplement, since ZnAAs
do not compete with other metals for zinc transporters and seem
FIGURE 4 | (A) Brain sections from three animals per group were used for immunohistochemistry. DAPI (labeling cell nuclei) and GFAP was visualized and
fluorescent signal intensities from 10 cells in the hippocampus from three sections per animal measured. Mean values show the average of three animals per group.
Upper panel: A significant increase in GFAP expression levels can be detected in the brains of mice subjected to zinc deficiency and lowered bioavailability (Zn
Inhibitor) compared to control mice. Lower panel: No significant difference in the number of GFAP positive cells per optic field of view (OFV) was found. Scale
bar = 100 µm. (B) Whole-brain total RNA lysate from three animals per group was used to analyze the expression of IL-6 on gene level normalized to Hmbs.
A significantly higher IL-6 expression was found in the brain of zinc-deficient mice. (C) Whole-brain protein lysate from three animals per group was used to analyze
IL-6 expression on protein level normalized to ACTIN. Significantly higher IL-6 levels are found in the brain of zinc-deficient mice.
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FIGURE 5 | (A) Whole-blood Zn levels of mice measured by AAS in three animals per group. Mice were fed ZnAA supplemented diet (diet 4, Zn Inhibitor + ZnAA). At
the end of pregnancy (8 weeks treatment in total), mice on a diet with control zinc levels (35 ppm) but bioavailability of zinc lowered due to the presence of
antagonists of absorption (Zn inhibitor) show significantly lower whole-blood zinc levels compared to mice on the same diet with the addition of ZnAAs.
(B) Pyrosequencing of 16S rDNA of fecal samples shows that the abundance of Proteobacteria is significantly higher in mice on Zn inhibitor + ZnAA diet compared
to mice on Zn inhibitor diet. The levels were still significantly lower compared to mice on the control diet. (C) Left panel: On species level, the almost 10-fold increase
in Ruminiclostridium cellobioparum seen in mice on Zn Inhibitor diet was partially prevented. Right panel: Bacteria of the genus Christensiella, Anaerotruncus,
Faecalibacterium, Acetatifactor, Desulfonispora, Ercella, Sporobacter, Holdenmanella, Kiloniella, Rhodospirillum, Caldimones, Brachymonas, Xenophilus, and
Desulfovibrio were highly reduced or absent in mice on Zn inhibitor diet. Supplementation with ZnAA was able to prevent the reduction/loss for Christensiella,
Anaerotruncus, Faecalibacterium, Acetatifactor, Desulfonispora, Holdenmanella, Rhodospirillum, Brachymonas, and Desulfovibrio. (D) GI epithelium was isolated
from three mice per group and protein lysates analyzed using Western blotting. Supplementation with ZnAA was able to prevent the significant increase of
ZONULIN1 observed in mice on Zn Inhibitor diet. Data for Control and Zn Inhibitor diet has been reused from Figure 3C. (E) Liver LPS is significantly increased in
mice on Zn inhibitor diet, but not in mice on Zn inhibitor + ZnAA diet. (F) Brain sections from three animals per group were used for immunohistochemistry. DAPI
(labeling cell nuclei) and GFAP or IL-6 were visualized and fluorescent signal intensities from 10 cells in the hippocampus from three sections per animal measured.
Mean values show the average of three animals per group. (F) A significant increase in GFAP expression levels can be detected in the brains of mice on the Zn
Inhibitor diet compared to control mice. Dietary supplementation with ZnAA slightly, but non-significantly decreased GFAP expression levels.
to be less accessible for folic acid or phytic acid. Therefore, here,
we supplemented a diet rich in zinc uptake antagonists (diet 3,
Zn Inhibitor) using ZnAAs to investigate whether the observed
changes can be prevented by dietary zinc supplementation.
Mice were fed a ZnAA supplemented diet (diet 4, Zn
Inhibitor + ZnAA) for 8 weeks. At the end of pregnancy,
the average whole-blood zinc levels were investigated and
compared to mice on the same diet with low bioavailability
of zinc but without zinc supplementation and controls. The
results show that the addition of ZnAAs to the diet leads
to significantly higher zinc levels compared to mice on the
diet with low bioavailability of zinc (t-test, p = 0.0225)
(Figure 5A) and no significant difference can be seen compared
to controls (p = 0.0736).
Next, we examined if alterations in microbiota composition
are normalized by zinc supplementation. We again performed
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pyrosequencing of 16S rDNA of fecal samples and investigated
the microbiome of mice fed ZnAA supplemented diet
(Figure 5B). The results show that on phylum level, the
abundance of Proteobacteria was significantly higher in mice
supplemented with ZnAA compared to mice on a diet with
lowered bioavailability of zinc. However, the levels did not
reach those of mice on a control diet (one way ANOVA,
p = 0.0004; Tukey post hoc analysis: Control vs. Zinc Inhibitor,
p < 0.01; Control vs. Zinc inhibitor + ZnAA, p < 0.01;
Zinc Inhibitor vs. Zinc inhibitor + ZnAA, p < 0.01). We
could not detect further rescue effects on phylum level.
Instead, supplementation with ZnAA seemed to generate
a new microbiota composition, which was significantly
different from controls and mice on the Zn Inhibitor diet
(Supplementary Figure S3A). Therefore, we focused on
the most prominent alterations observed in mice on a diet
with low bioavailability of zinc on genus and species level
and compared these to mice on the same diet, but with
supplementation of ZnAAs. An almost 10-fold increase in
Ruminococcus (R. cellobioparum) was observed under the
low bioavailability of zinc. Supplementation with ZnAAs
was able to partially prevent this increase (Figure 5C,
left panel) (one way ANOVA, p = 0.0005; Tukey post hoc
analysis: Control vs. Zinc Inhibitor, p < 0.01; Control vs.
Zinc inhibitor + ZnAA, p < 0.01; Zinc Inhibitor vs. Zinc
inhibitor+ ZnAA, p < 0.01). Bacteria of the genus Christensiella,
Anaerotruncus, Faecalibacterium, Acetatifactor, Desulfonispora,
Ercella, Sporobacter, Holdenmanella, Kiloniella, Rhodospirillum,
Caldimones, Brachymonas, Xenophilus, and Desulfovibrio
were highly reduced or absent in mice on Zn inhibitor diet.
On genus level, supplementation with ZnAA was able to
prevent many of these losses (Figure 5C, right panel) (one way
ANOVA followed by Tukey post hoc analysis). For example, no
decrease in the Faecalibacterium genus that may be beneficial
to the host concerning inflammatory processes (Sokol et al.,
2008) was seen.
Interestingly, supplementation with ZnAA was able to prevent
the loss of ZONULIN1 observed in mice on Zn Inhibitor diet
(Figures 3C, 5D) (one way ANOVA, p = 0.0219; Tukey post hoc
analysis: Control vs. Zinc Inhibitor, p = 0.0186; Control vs. Zinc
inhibitor + ZnAA, p = 0.34). In addition, the levels of liver LPS
decreased and were no longer significantly different from mice
on control diet (Figure 5E) (one way ANOVA, p = 0.0065; Tukey
post hoc analysis: Control vs. Zinc Inhibitor, p < 0.01; Control vs.
Zinc inhibitor+ ZnAA, p = 0.05738).
In the brain, we could not observe a significant effect on
astrocyte activation, as animals on Zinc inhibitor + ZnAA diet
still showed a significant increase in GFAP expression, although
slightly less compared to mice on Zinc inhibitor diet (one
way ANOVA, p = 0.0044; Tukey post hoc analysis: Control vs.
Zinc Inhibitor, p = 0.0039; Control vs. Zinc inhibitor + ZnAA,
p = 0.0219) (Figure 5F). In contrast, while mice on Zinc
inhibitor diet had significantly increased IL-6 brain tissue levels,
we detected no difference between Controls and mice on Zinc
inhibitor diet supplemented with ZnAAs (Supplementary Figure
S3B). Thus, zinc supplementation was able to prevent an increase
in IL-6 brain levels.
DISCUSSION
Zinc deficiency plays a role in the etiology of depressive disorders
in mouse models and humans. Several studies have reported an
inverse relationship between low zinc levels and higher Hamilton
Depression Rating Scale scores in patients (Maes et al., 1994).
Interestingly, zinc deficiency also impairs the efficacy of several
antidepressants (Tassabehji et al., 2008; Młyniec and Nowak,
2012; Młyniec et al., 2012). However, the mechanisms behind are
not fully understood.
Further abnormalities have been independently reported in
animal models and human patients with depression such as
alterations in the gut microbiota composition and increased
inflammatory responses and chronic inflammation. Several
studies in the past revealed a link between depression and
altered gut microbiota composition. From these a motif emerged,
where significant alterations in the abundance of gut microbiota
within the phyla Bacteroidetes, Firmicutes, Proteobacteria,
and Actinobacteria were reported in patients diagnosed with
major depressive disorder, but also in relevant rodent models
(Winter et al., 2018).
With regards to inflammation, it was found that patients
with major depressive disorder show all of the key features
of an inflammatory response such as increased expression of
pro-inflammatory cytokines and chemokines, cytokine receptors,
and soluble adhesion molecules in peripheral blood and
cerebrospinal fluid (CSF) (Miller and Raison, 2016). Especially,
increased expression of IL-1β, IL-6, TNF, Toll-like receptor
3 (TLR3) and TLR4, has been found in post-mortem brains
(Maes, 1995; Brambilla et al., 2014; Drago et al., 2015) and
consistent with this, activation of IL-6, IL-8 and type I IFN-
induced signaling pathways has been reported (Brambilla et al.,
2014). A meta-analysis found that IL-1β, IL-6, TNF and
C-reactive protein (CRP) in peripheral blood are the most
reliable biomarkers of inflammation in patients with depression
(Miller et al., 2009).
Here, we sought to establish a link between maternal zinc
deficiency, altered microbiota composition, and inflammation.
Zinc deficiency was reported before to affect microbiota
composition. For example, similar to the result reported here, a
decrease in Veruccomicrobia and an increase in Firmicutes has
been observed (Mayneris-Perxachs et al., 2016). The low relative
abundance of Verrucomicrobia populations and a decrease
in beneficial bacteria was correlated with zinc deficiency in
further studies (Lopez and Skaar, 2018). In addition, low
zinc status as well as zinc supplementation were reported to
affect gut microbiota in chicken (Reed et al., 2015, 2018).
However, to our knowledge, the effects of zinc deficiency on the
microbiome of pregnant mice in light of the observed behavioral
alterations in the offspring of zinc-deficient mothers has not been
investigated so far.
Using pyrosequencing of 16S rDNA of fecal samples, we
obtained microbiota profiles from animals on four different
diets: a control diet, a diet low in zinc, a diet with low
bioavailability of zinc induced by elevated concentrations of
other dietary components such as Fe, Ca, and folic acid that
are commonly prescribed to pregnant women, and a diet with
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low bioavailability that was supplemented with zinc in the form
of ZnAA to overcome inhibition by zinc uptake antagonists
present in this diet (Sauer et al., 2017). Although no clear
cut-off values between hypozincemia and zinc deficiency are
established for mice, we consider the status of mice on a zinc-
deficient diet and diet with zinc uptake inhibitors as mild zinc
deficient. This is based on the fact that in many cases, in
human studies, hypozincemia cannot be picked up in blood
samples and blood/plasma zinc content is generally considered
a poor measure of marginal zinc deficiency in humans (King,
1990; Wood, 2000). However, in our study, both animals on
the zinc-deficient diet and diet with uptake inhibitors show
significantly reduced zinc levels in blood. On the other hand,
severe zinc deficiency was shown to induce gross anatomical
malformation in pups from rats with severe zinc deficiency
(Hurley et al., 1971). The pups born from pregnant mice in
this study did have similar birth weight, no malformations and
no statistically significant difference in the number of pups was
detected in the different treatment groups compared to controls.
Therefore, we conclude that the zinc deficiency we created was
not severe but mild.
While both mice on a zinc-deficient diet and mice on a diet
low in the bioavailability of zinc showed low tissue zinc levels
and alterations in gut microbiota composition, the observed
alterations in microbiota were not identical.
Mice on a zinc-deficient diet showed an increase in the
phylum Actinobacteria and Bacteroidetes. Actinobacteria belong
to the dominant commensal communities in humans and mice
(Qin et al., 2010) and are generally regarded as pathobionts.
Under certain circumstances, they are known to promote
disease. In particular, Actinobacteria are associated with chronic
inflammatory conditions and, for example, an increase in
Actinobacteria has been associated with Inflammatory Bowel
Disease (Frank et al., 2007; Morgan et al., 2012). However, mice
on a diet with low bioavailability of zinc showed no such increase
in Actinobacteria and Bacteroidetes.
Both groups of mice, however, showed an increase in
Firmicutes and a decrease in Proteobacteria. In previous studies
using mouse models for stress and depression-like behavior, an
increase in Actinobacteria (Bangsgaard Bendtsen et al., 2012),
both an increase and a decrease in Bacteroidetes (Aoki-Yoshida
et al., 2016; Bharwani et al., 2016), an increase in Firmicutes
(Aoki-Yoshida et al., 2016), as well as a decrease in Proteobacteria
(Galley et al., 2014; Aoki-Yoshida et al., 2016) has been reported.
Therefore, although different in some aspects both mice on a
zinc-deficient diet and mice on a diet low in the bioavailability
of zinc show alterations similar to those reported in models for
stress and depression-like behavior.
The differences may originate in the competition between
gut microbiota and enterocytic zinc uptake transporters for
zinc. In mice on a zinc-deficient diet, a low amount of zinc is
available for both. In contrast, in the diet with low bioavailability
of zinc, zinc levels are normal but zinc uptake by enterocytic
zinc transporters is inhibited through the antagonists present
in the diet. Some microbiota may have an advantage over
enterocytic zinc transporters with respect to inhibition by
antagonists and may still be able to access sufficient amounts
of zinc. For example, the phylum Verrucomicrobia was hardly
affected by low bioavailability of zinc but reacted strongly
to low general zinc levels. Further, due to low zinc levels,
some families of bacteria may gain an advantage either by
less demand for zinc, more sufficient intake mechanisms, or
lack of competition through more zinc sensitive bacteria. For
example, bacteria in the phylum Firmicutes were significantly
increased in both zinc restricted diets. In addition, the presence
of the zinc uptake inhibitors phytic acid, Ca, Fe, and folic
acid may additionally influence microbiota. Therefore, it is
not expected that a zinc-deficient diet and a diet with low
bioavailability will alter microbiota composition in identical
ways. However, besides shared and unique features in microbiota
composition, both groups of animals show a reduction in tight
junction markers and increased liver LPS levels. Thus, the shared
aberrations from an established gut microbiota composition
and/or low availability of zinc for GI cells are associated with
pathological changes, such as increased permeability in the GI
system in these mice.
Several studies support the idea that intestinal barrier
dysbiosis leads to inflammatory responses in peripheral tissues
and may ultimately drive inflammation in the brain. Therefore,
we investigated the brain for characteristic alterations using
GFAP and IL-6 as markers. We detected significantly higher
GFAP expression in the brain of mice on zinc-restricted
diets. Increased GFAP expression is a marker for activation
on astrocytes and inflammation (Zhang et al., 2017). Our
results are in line with previous reports that acute stress
increases GFAP expression in the hippocampus of rodents
(Lambert et al., 2000). Zinc deficiency may physiologically act as
an acute stressor.
IL-6 plays a key role in the development of stress-associated
depression-like behaviors in mice (Chourbaji et al., 2006). IL-6
signaling can result from activation of inflammatory pathways
and alterations in IL-6 levels in the brain were demonstrated
contributing to depression symptomatology (Hodes et al., 2016).
Indeed, IL-6 is consistently reported as elevated in the blood
of patients with depression (Haapakoski et al., 2015) and has
been proposed as a predictive biomarker. Therefore, here, we
assessed IL-6 levels in the brain mice. Our data show increased
IL-6 tissue levels on mRNA and protein levels in response to
low zinc status in pregnant mice. These results are in line
with previously reported results showing up-regulation of cell
activation markers in THP1 cells, a model for human monocytes,
that coincided with increased IL-6 responses following LPS
stimulation (Wong et al., 2015). In addition, a decreased zinc
status in aged mice was associated with increased IL-6 expression
levels (Wong et al., 2015).
Finally, supplementation of the diet with low bioavailability of
zinc with ZnAAs was investigated to validate the contribution of
zinc deficiency to the observed alterations and to understand the
usability of ZnAAs for zinc supplementation during pregnancy.
Supplementation with ZnAAs was able to prevent a significant
drop in zinc levels in the maternal blood. In terms of
microbiota composition, the presence of the ZnAA supplement
is not expected to create a similar condition as observed in
controls due to the presence of zinc uptake antagonists and
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increased zinc levels. However, supplementation with ZnAA
may reverse some effects caused by lowered bioavailability of
zinc due to the presence of the antagonists. Indeed, ZnAA
supplementation ameliorated the decrease in Proteobacteria. In
addition, supplementation with ZnAAs prevented the decrease
in Actinobacteria and Bacteroidetes, which was specific for this
diet. However, it leads to an increase of both phyla as observed
in the zinc-deficient diet before. Both phyla, therefore, seem
to respond very sensitive to zinc levels and possibly contain
species that thrive in low zinc conditions and others that
strive with high zinc levels. Therefore, it is more important to
investigate alterations on the genus and species level. Here, ZnAA
supplementation ameliorated alterations observed before in
several genera such as Anaertruncus, Acetifactor, Desulfonispora,
Holdemanella, Rhodospirillum, and Desulfovibrio.
In terms of GI pathology, we could no longer detect an
increase in ZONULIN1 levels in ZnAA supplemented mice and,
in line with this, no significant increase in liver LPS. Thus,
effects on gut physiology seem indeed to be dependent on zinc
availability much more than on microbiota composition and it
can be assumed that alterations in microbiota composition are
a consequence of altered GI function or dependent on dietary
factors only, or both. The reduction in GI abnormalities and
liver LPS are expected to decrease pro-inflammatory processes
in the mice. While we could not detect a normalization of
GFAP expression, IL-6 protein levels in brain tissue were indeed
normalized. While IL-6 levels in the brain of humans are
difficult to measure, a reduction of IL-6 levels in plasma after
zinc supplementation has been reported also in humans before
(Bao et al., 2010). The data further confirms that ZnAAs are
not only increasing zinc levels in animals but that they are
biologically active.
Taken together, we conclude that both low levels of zinc
or the presence of zinc uptake inhibitors that are commonly
found in western diets and supplements for pregnant women
alter the microbiome of pregnant mice. This may not only play
a role in the observed autism-like phenotype of the offspring
of mice with zinc deficiency during pregnancy but may also
directly influence brain functionality through altered gut-brain
signaling. Low zinc status was associated with changes in the
intestinal epithelial barrier and an increase in liver LPS hints
at increased leakiness of the gut in response to these changes.
Finally, this may contribute to increased inflammation as we
have observed higher GFAP and IL-6 levels in the brain of
mice. Acute zinc deficiency was linked to depression and a
role of microbiota dysbiosis and inflammation suggested. Our
results obtained from pregnant mice do not exclude that similar
alterations may occur independent of pregnancy in response to
low zinc status. Based on our results, as low availability of zinc
during pregnancy influences both microbiota and inflammatory
status, a link between maternal zinc deficiency and postpartum
depression seems plausible.
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